Skip to main content
Log in

Pegfilgrastim least costly for chemo-induced neutropenia

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Lago S, Nasciben V, Saggia MG.Cost-minimization analysis of once-per-cycle fixed-dose administration of pegfilgrastim versus daily filgrastim for the prophylaxis of chemotherapy-induced febrile neutropenia in Brazil. Value in Health 10: 332 (plus oral presentation) abstr. PCN33, No. 6, Nov-Dec 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pegfilgrastim least costly for chemo-induced neutropenia. Pharmacoecon. Outcomes News 540, 9 (2007). https://doi.org/10.2165/00151234-200705400-00017

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705400-00017

Keywords

Navigation